Next Up:
0:00
0:00
-
Listen Listen
Health
Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the makers of Wegovy and Mounjaro are seeking FDA approval for tablets.
Sponsored message
More Stories
-
Storm runoff may have contaminated ocean and bay recreational waters.
-
L.A. County public health officials have said the individual was an older adult with underlying health conditions and encouraged all eligible residents to get vaccinated against influenza.
-
With a new flu virus variant circulating, scientists fear more sickness this winter. The vaccine may be slightly less effective, but doctors still urge getting one ASAP.
-
It's trendy in some circles to replace drinking with consuming cannabis. But can it help people with a drinking problem cut back? Scientists set up a bar in the lab to find out.
-
A new bill sponsored by Sens. Adam Schiff and Alex Padilla would explore landmark respiratory protections to shield wildland firefighters from dangerous wildfire smoke.
-
Federal law allows Immigration and Customs Enforcement agents to guard detainees at health care facilities, but patients can ask to speak privately with medical providers and lawyers.
-
Hundreds of people are on a waitlist for opioid addiction treatment in Los Angeles County jails as the state presses the system to reduce overdoses and in-custody deaths
-
Labor and health care groups are collecting signatures to put a measure that would levy a one-time 5% tax on the wealth of about 200 billionaires in California.
-
The science around hormone therapy to treat menopause has changed a lot since the FDA issued warning labels 20 years ago. Now the labels are being removed, here are 6 things to consider.
-
With the contest a year away, polling shows voters want the next governor to minimize out-of-pocket health care costs, increase mental health care, and expand caregiving services.
-
The guidance says that such people could become a “public charge” — a potential drain on U.S. resources — because of their health issues or age.
-
Hormone therapy drugs have carried box warning labels for years. Food and Drug Administration Commissioner Marty Makary talks with NPR about why the agency is removing them.